Predictors of endothelial dysfunction in young women with polycystic ovary syndrome
- PMID: 15985492
- DOI: 10.1210/jc.2005-0151
Predictors of endothelial dysfunction in young women with polycystic ovary syndrome
Abstract
Context: Women with polycystic ovary syndrome (PCOS) may be at increased risk for cardiovascular disease. Endothelial dysfunction is an early marker of atherosclerosis.
Objectives: The objectives of this study were to 1) compare endothelial function in young women with PCOS and regularly menstruating control women, and 2) to identify the determinants of endothelial function and investigate its relationship with body mass index in women with PCOS.
Design: This was a cross-sectional study.
Setting: This study was conducted at a tertiary cardiovascular research center.
Patients: Sixty-two young women with PCOS (mean age, 22.7 yr) and 17 control women, matched as a group for age and body mass index, were studied. Twenty-three women with PCOS were lean, 21 were overweight, and 18 were obese.
Main outcome measures: Endothelium-dependent and -independent vascular function was assessed by measuring flow-mediated dilation (FMD) and nitrate-mediated dilation in the brachial artery (diameter change during hand hyperemia and after sublingual glyceryl trinitrate administration, respectively).
Results: FMD and nitrate-mediated dilation were significantly lower in PCOS than in control women (reduced by approximately 50 and 25%, respectively; both P < 0.0005). Insulin resistance, total testosterone, and total cholesterol were independent predictors of FMD, accounting for 21, 10, and 9% of the variance, respectively (P < 0.005 for all). A trend of deterioration in FMD from lean to overweight and obese PCOS women was observed, but differences among groups were not statistically significant.
Conclusions: Women with PCOS have significant endothelial dysfunction at an early age (i.e. early 20s), and largely independent of obesity. This suggests that women with PCOS are at increased risk for early onset cardiovascular disease and may gain particular benefit from measures to improve endothelial function.
Similar articles
-
Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.BJOG. 2006 Nov;113(11):1308-14. doi: 10.1111/j.1471-0528.2006.01090.x. BJOG. 2006. PMID: 17059392
-
Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.Clin Endocrinol (Oxf). 2006 Nov;65(5):655-9. doi: 10.1111/j.1365-2265.2006.02645.x. Clin Endocrinol (Oxf). 2006. PMID: 17054469
-
Endothelial dysfunction in PCOS: role of obesity and adipose hormones.Am J Med. 2006 Apr;119(4):356.e1-6. doi: 10.1016/j.amjmed.2005.10.059. Am J Med. 2006. PMID: 16564785
-
[Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women].Monaldi Arch Chest Dis. 2006 Mar;66(1):48-53. doi: 10.4081/monaldi.2006.540. Monaldi Arch Chest Dis. 2006. PMID: 17125045 Review. Italian.
-
Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?Metabolism. 2015 Nov;64(11):1564-73. doi: 10.1016/j.metabol.2015.08.010. Epub 2015 Aug 20. Metabolism. 2015. PMID: 26386695 Review.
Cited by
-
Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia.Pediatr Cardiol. 2014 Jan;35(1):63-70. doi: 10.1007/s00246-013-0742-0. Epub 2013 Jul 3. Pediatr Cardiol. 2014. PMID: 23821294
-
Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study.J Endocrinol Invest. 2017 Apr;40(4):377-384. doi: 10.1007/s40618-016-0570-1. Epub 2016 Oct 22. J Endocrinol Invest. 2017. PMID: 27771865
-
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.touchREV Endocrinol. 2021 Apr;17(1):37-53. doi: 10.17925/EE.2021.17.1.37. Epub 2021 Apr 28. touchREV Endocrinol. 2021. PMID: 35118445 Free PMC article. Review.
-
Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome.J Endocrinol Invest. 2008 Nov;31(11):1001-7. doi: 10.1007/BF03345639. J Endocrinol Invest. 2008. PMID: 19169057
-
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.Curr Diab Rep. 2017 Nov 11;17(12):137. doi: 10.1007/s11892-017-0956-2. Curr Diab Rep. 2017. PMID: 29128916 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical